V

Viridermics

Organization

Heard in 1 episode across 1 show since Oct 2026

Viridermics is a clinical-stage biotechnology company developing therapies for inflammatory and dermatologic diseases.

Email alerts

Episodes

1
across 1 show

First heard

Oct 2026

Expert statements

2
2 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20260
Sep 20260
Oct 20261

Email alert

Email me when Viridermics comes up on a podcast

One email a week at most, with the new episodes that mention Viridermics. Free, no account needed, unsubscribe in one click.

What experts have said about Viridermics

2 statements · 2 positive

  1. Simeon J. GeorgePositiveOct 12, 2026· Business Of Biotech

    Viridermics was the year’s best-performing IPO at that point.

    “I think it's been the best performing IPO of any IPO that's happened this year.”

    Listen at 12:40

    Open the episode · AI, China, And Biotech Investing With SR One's Simeon George, M.D.
  2. Simeon J. GeorgePositiveOct 12, 2026· Business Of Biotech

    Viridermics was the year’s best-performing IPO at that point.

    “the best performing IPO of any IPO that's happened this year”

    Listen at 12:40

    Open the episode · AI, China, And Biotech Investing With SR One's Simeon George, M.D.
Filter the statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

1 episode featuring Viridermics, newest first